Kamada Ltd. (KMDA)
NASDAQ: KMDA · IEX Real-Time Price · USD
5.15
-0.05 (-0.96%)
Apr 26, 2024, 4:30 PM EDT - Market closed
Kamada Revenue
In the year 2023, Kamada had annual revenue of $142.52M with 10.19% growth. Revenue in the quarter ending December 31, 2023 was $36.43M, a -19.82% decrease year-over-year.
Revenue (ttm)
$142.52M
Revenue Growth
+10.19%
P/S Ratio
2.08
Revenue / Employee
$377,034
Employees
378
Market Cap
295.99M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
Dec 31, 2019 | 127.19M | 12.72M | 11.11% |
Dec 31, 2018 | 114.47M | 11.64M | 11.32% |
Dec 31, 2017 | 102.83M | 25.33M | 32.69% |
Dec 31, 2016 | 77.49M | 7.59M | 10.85% |
Dec 31, 2015 | 69.91M | -1.16M | -1.63% |
Dec 31, 2014 | 71.07M | 442.00K | 0.63% |
Dec 31, 2013 | 70.62M | -2.05M | -2.82% |
Dec 31, 2012 | 72.68M | 13.19M | 22.18% |
Dec 31, 2011 | 59.48M | 25.01M | 72.53% |
Dec 31, 2010 | 34.48M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sharecare | 445.25M |
Procaps Group | 414.10M |
GeneDx Holdings | 202.57M |
Verrica Pharmaceuticals | 5.12M |
Nyxoah | 4.83M |
XOMA Corporation | 4.76M |
KMDA News
- 7 weeks ago - Kamada Issues 2024 CEO Letter to Shareholders - GlobeNewsWire
- 7 weeks ago - Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability - GlobeNewsWire
- 2 months ago - Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024 - GlobeNewsWire
- 5 months ago - KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB® - PRNewsWire
- 5 months ago - Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years - GlobeNewsWire
- 5 months ago - Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance - GlobeNewsWire
- 6 months ago - Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023 - GlobeNewsWire
- 7 months ago - Kamada Provides Corporate Update on its Israel Operations - GlobeNewsWire